INTRODUCTION
These interactive cases will address the most clinically relevant data on Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia.
Launch Date: December 10, 2020
Release Date: December 4, 2020
Expiration Date: November 30, 2021
TARGET AUDIENCE
This activity is intended for physicians, physician assistants, nurse practitioners, and registered nurses who treat/manage patients with Acute Leukemia.
LEARNING OBJECTIVES
Upon completion of this enduring material, participants should be able to:
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CNE information.
- Review the two case studies associated with this course.
- Successfully complete the post-test ( accuracy) for each case study.
- Complete the CME/CNE evaluation.
- The estimated time to complete each case study is hour.
JOINT PROVIDERSHIP
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, and Practice Point Communications.
ACCREDITATION STATEMENTS
PHYSICIANS
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES
The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is provided for contact hour under ANCC criteria.
RESOLUTION OF CONFLICT OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, the University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska College of Nursing Continuing Nursing Education, and Practice Point Communications will implement mechanisms, prior to the planning and implementation of this CME/CE activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME/CE activity.
DISCLOSURE
All planners and faculty participating in continuing education activities provided by the University of Nebraska Medical Center, Center for Continuing Education and the University of Nebraska Medical Center College of Nursing Continuing Nursing Education are expected to disclose to the audience any support or relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. A commercial interest is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in activity materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. The planners and faculty have been advised that this activity must be free from commercial bias and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
All materials are included with the permission of the authors. The opinions expressed are those of the authors and are not to be construed as those of the University of Nebraska Medical Center, Center for Continuing Education and the University of Nebraska Medical Center College of Nursing Continuing Nursing Education.
The following indicates the disclosure declaration information and the nature of those commercial relationships.
DISCLOSURES
The speakers and planning committee members listed below have stated they have no relationships to disclose.
Heidi Keeler, PhD, RN
Renee Paulin, MSN, RN, CWOCN
Brenda Ram, CMP, CHCP
Chris Fleming
Martin Stevens
The following speakers and/or planners have stated that they have the following financial relationship(s), and they have agreed to see that all information they planned and/or present is done so fairly and without bias:
FACULTY DISCLOSURES
Richard M. Stone, MD
Chief of Staff at Dana-Farber Cancer Institute (DFCI). Director of Translational Research, Leukemia Division of Medical Oncology at DFCI, and Professor of Medicine at Harvard Medical School.
Boston, MA
Securities, employment, promotional activities, intellectual property, gifts, grants: None
Steering Committees: AbbVie, Agios
Advisory Boards: Actinium, Amgen, Astellas, BioLineRx, ElevateBio, GEMoaB, Janssen, MacroGenics, Novartis, Syndax Pharma, Syros, Takeda, Trovagene
Research Funding: Arog, Novartis
Consulting: Daiichi-Sankyo, Novartis
Data and Safety Monitoring Board: Celgene, Syntrix/ACL Clinical
The faculty may include discussion on off-label or unapproved uses of a commercial product, or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information of any medication mentioned in this educational activity before its use.
Farhad Ravandi, MD
Janiece and Stephen A. Lasher Professor of Medicine,
Chief, Section of Acute Myeloid Leukemia, Department of Leukemia,
The University of Texas – MD Anderson Cancer Center, Houston, Texas
Industry Funded Research: AbbVie, Amgen, BMS, Jazz, Xencor
Advisory Boards: Amgen, Astellas, AstraZeneca, BMS, Celgene, Jazz, Xencor
Consultant: Amgen, Astellas, AstraZeneca, BMS, Celgene, Jazz
Stock/Ownership: none
Patent holder: none
Other (please describe): none
The faculty may include discussion on off-label or unapproved uses of a commercial product, or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information of any medication mentioned in this educational activity before its use.
DISCLAIMER
The University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, and Practice Point Communications present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, Practice Point Communications, and Amgen, Inc. or Astellas Pharma Global Development Medical Affairs assume no liability for the information herein. Accredited status as a continuing nursing education provider refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities and does not imply the University of Nebraska Medical Center or American Nurses Credentialing Center's Commission on Accreditation endorsement of any commercial supporters.
PRIVACY POLICY
The University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, and Practice Point Communications protect the privacy of personal and other information regarding participants and educational collaborators. The University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, and Practice Point Communications will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME, ANCC, or ACPE.
The University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, and Practice Point Communications maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
COPYRIGHT INFORMATION
Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:
The Materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without prior written permission.
HARDWARE/SOFTWARE REQUIREMENTS
Computer:
- Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
- Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution.
- Network: An Internet connection with 1Mbps available download & 256kbps bandwidth.
Software/Browser:
- Windows 7 or above running Internet Explorer 10 or above.
- MAC OSX 10.5 (Leopard) or above running Safari 6 or above, or any version of Chrome, Firefox or Opera published in the last two years.
- A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above.
Mobile Device:
- Any Apple iPad or iPad Mini running iOS 7.1 or above.
- Android tablets such as the Kindle Fire or Samsung Galaxy S.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
Supported by independent educational grants from Amgen, Inc., and Astellas Pharma Global Development, Inc.